- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation
Description
<jats:p>Viral infection, especially with rhinovirus (RV), is a major cause of asthma exacerbation. The production of anti-viral cytokines such as interferon (IFN)-β and IFN-α from epithelial cells or dendritic cells is lower in patients with asthma or those with high IgE, which can contribute to viral-induced exacerbated disease in these patients. As for virus-related factors, RV species C (RV-C) induces more exacerbated disease than other RVs, including RV-B. Neutrophils activated by viral infection can induce eosinophilic airway inflammation through different mechanisms. Furthermore, virus-induced or virus-related proteins can directly activate eosinophils. For example, CXCL10, which is upregulated during viral infection, activates eosinophils<jats:italic>in vitro</jats:italic>. The role of innate immune responses, especially type-2 innate lymphoid cells (ILC2) and epithelial cell-related cytokines including IL-33, IL-25, and thymic stromal lymphopoietin (TSLP), in the development of viral-induced airway inflammation has recently been established. For example, RV infection induces the expression of IL-33 or IL-25, or increases the ratio of ILC2 in the asthmatic airway, which is correlated with the severity of exacerbation. A mouse model has further demonstrated that virus-induced mucous metaplasia and ILC2 expansion are suppressed by antagonizing or deleting IL-33, IL-25, or TSLP. For treatment, IFNs including IFN-β suppress not only viral replication but also ILC2 activation<jats:italic>in vitro</jats:italic>. Agonists of toll-like receptor (TLR) 3 or 7 can induce IFNs, which can then suppress viral replication and ILC2 activation. Therefore, if delivered in the airway, IFNs or TLR agonists could become innovative treatments for virus-induced asthma exacerbation.</jats:p>
Journal
-
- Frontiers in Immunology
-
Frontiers in Immunology 13 2022-06-20
Frontiers Media SA
- Tweet
Keywords
- Inflammation
- Rhinovirus
- Immunology
- innate lymphoid cells
- Interferon-alpha
- epithelial cell-related cytokines
- Interferon-beta
- RC581-607
- Interleukin-33
- Antiviral Agents
- Asthma
- Immunity, Innate
- Mice
- rhinovirus
- Enterovirus Infections
- Animals
- Cytokines
- bronchial asthma
- eosinophils
- Lymphocytes
- Immunologic diseases. Allergy
Details 詳細情報について
-
- CRID
- 1360017282433515264
-
- ISSN
- 16643224
-
- PubMed
- 35795686
-
- Article Type
- journal article
-
- Data Source
-
- Crossref
- KAKEN
- OpenAIRE